ArticleBone & joint research2025
Design and mechanical evaluation of a novel dynamic growth rod to improve the surgical treatment of early-onset scoliosis.
Article in Bone & joint research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Durable responses to long-term selumetinib in Chinese pediatric NF1 patients with inoperable plexiform neurofibromas.Frontiers in pharmacology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aims: Growth rods are the gold standard for treating early-onset scoliosis (EOS), but current treatments often fail to optimally promote spinal growth and require frequent distraction surgeries, leading to complications and significant burdens on patients. Methods: We designed a novel growth rod (NGR) with unidirectional sliding and external regulation capabilities. Using a 3D model, we simulated the implantation of traditional growth rod (TGR) and NGR, applying a 400 N compressive load and a 1 Nm moment to test stiffness. We assessed spinal joint range of motion and growth rod stress distribution, and calculated axial force, moment, and fatigue life. Results: The axial compressive and torsional stiffness of the NGR were higher than those of the TGR and the intact group. The Von Mises stress values of the NGR under all conditions were higher than those of the TGR. Additionally, the fatigue life of the NGR met basic daily living requirements. Overall, the NGR demonstrated superior stiffness and stress distribution, with stress primarily concentrated near the screw fixation points and distributed along the titanium rods. Conclusion: The NGR, based on a distraction implant, includes a unidirectional sliding component and a spring-driven component, providing dynamic correction functionality. Additionally, it features a novel non-invasive lengthening mechanism that reduces the risk of infection. Compared to the current market-leading EOS implants, it offers enhanced stability. The novel device can potentially improve clinical outcomes in the surgical treatment of EOS.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.